Reuters logo
BRIEF-Peregrine Pharmaceuticals Q3 loss per share $0.04
March 13, 2017 / 8:50 PM / 9 months ago

BRIEF-Peregrine Pharmaceuticals Q3 loss per share $0.04

March 13 (Reuters) - Peregrine Pharmaceuticals Inc

* Sees FY 2017 revenue from avid bioservices business of $60 million-$65 million

* Increasing FY Avid Bioservices business manufacturing revenue outlook to $60 - $65 million from $50 - $55 million

* Peregrine pharmaceuticals reports financial results for the third quarter of fiscal year 2017 and recent developments

* Q3 loss per share $0.04 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below